Moreover, according to the 2023 guidelines of the American Diabetes Association, GLP-1 RAs are associated with numerous cardiovascular benefits in patients with T2DM with comorbidities of established atherosclerotic cardiovascular diseases (ASCVDs) [5]. This evidence concerns the gene GCG and type 2 diabetes mellitus.